SEPTERNA INC. - COMMON STOCK

Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results

27 مارس 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Septerna to Present at TD Cowen 45th Annual Health Care Conference

26 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist

18 فبراير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer

06 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

20 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

30 أكتوبر 2024 16:41:58 بحسب Nasdaq GlobeNewswire